Simplex Trading’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,100
| Closed | -$30K | – | 8949 |
|
|
2025
Q3 | $30K | Sell |
2,100
-28,400
| -93% | -$289K | ﹤0.01% | 6965 |
|
|
2025
Q2 | $299K | Sell |
30,500
-18,600
| -38% | -$154K | ﹤0.01% | 4070 |
|
|
2025
Q1 | $356K | Sell |
49,100
-22,600
| -32% | -$198K | ﹤0.01% | 3756 |
|
|
2024
Q4 | $560K | Buy |
71,700
+12,300
| +21% | +$101K | ﹤0.01% | 3401 |
|
|
2024
Q3 | $439K | Buy |
59,400
+1,800
| +3% | +$15.1K | ﹤0.01% | 3731 |
|
|
2024
Q2 | $461K | Sell |
57,600
-41,700
| -42% | -$372K | ﹤0.01% | 3753 |
|
|
2024
Q1 | $1.16M | Buy |
99,300
+5,200
| +6% | +$57.6K | ﹤0.01% | 2965 |
|
|
2023
Q4 | $1.05M | Buy |
94,100
+42,900
| +84% | +$394K | ﹤0.01% | 2960 |
|
|
2023
Q3 | $790K | Buy |
51,200
+24,500
| +92% | +$411K | ﹤0.01% | 2907 |
|
|
2023
Q2 | $505K | Buy |
26,700
+5,100
| +24% | +$89.6K | ﹤0.01% | 3309 |
|
|
2023
Q1 | $328K | Sell |
21,600
-29,000
| -57% | -$378K | ﹤0.01% | 3729 |
|
|
2022
Q4 | $644K | Sell |
50,600
-106,300
| -68% | -$956K | ﹤0.01% | 2916 |
|
|
2022
Q3 | $908K | Buy |
156,900
+126,300
| +413% | +$555K | ﹤0.01% | 2755 |
|
|
2022
Q2 | $98K | Buy |
+30,600
| New | +$92.4K | ﹤0.01% | 5575 |
|
|
2022
Q1 | – | Sell |
-100
| Closed | -$1K | – | 10644 |
|
|
2021
Q4 | $1K | Sell |
100
-300
| -75% | -$4.74K | ﹤0.01% | 10176 |
|
|
2021
Q3 | $7K | Hold |
400
| – | – | ﹤0.01% | 9104 |
|
|
2021
Q2 | $7K | Buy |
400
+395
| +7,900% | +$8.82K | ﹤0.01% | 9276 |
|
|
2021
Q1 | $11K | Buy |
+5
| New | +$115 | ﹤0.01% | 7836 |
|
Other funds holding ETNB
Simplex Trading's ETNB Position: Q4 2025 in Review
Simplex Trading sold out of 89bio (ETNB) in Q4 2025, closing a stake of 108,245 shares — an estimated $1.59M sold.
Simplex Trading first reported a position in ETNB in Q1 2021 and held it in 15 quarters. The position peaked at $2.4M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Simplex Trading reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 108,245 89bio shares in Q4 2025, an estimated $1.59M.
- Simplex Trading first reported a position in 89bio in Q1 2021 and held it in 15 quarters.
- Simplex Trading's 89bio position peaked at $2.4M in Q1 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.